Two-Colour Fluorescence Marker for Neurodegenerative Diseases
Worldwide it is estimated that there are 29 million cases of Alzheimer Disease (AD) and about 4 million of Parkinson's Disease (PD). The world market for AD and PD is estimated to be 14 billion dollars corresponding to an annual growth rate of 20%, making it an very attractive field for R&D to generate novel therapeuticals. Recently, the accumulation of dysfunctional mitochondria has been linked to neurodegenerative diseases, in particular to AD and PD. Scientists at the University of Göttingen have developed a powerful fluorescent marker for Live Cell Imaging to study mitochondrial dysfunctions and for testing novel pharmaceutical products
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
A universal framework for spatial biology
SpatialData is a freely accessible tool to unify and integrate data from different omics technologies accounting for spatial information, which can provide holistic insights into health and disease. Biological processes…
How complex biological processes arise
A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at…
Airborne single-photon lidar system achieves high-resolution 3D imaging
Compact, low-power system opens doors for photon-efficient drone and satellite-based environmental monitoring and mapping. Researchers have developed a compact and lightweight single-photon airborne lidar system that can acquire high-resolution 3D…